Healthcare provider profile · identity verified

Daniel S Kantz, D.O.

Family Practice · JEFFERSONVILLE, IN · NPI 1205965563

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	376	89
Eliquis	Apixaban	356	38
Levothyroxine Sodium	Levothyroxine Sodium	255	54
Amlodipine Besylate	Amlodipine Besylate	218	48
Omeprazole	Omeprazole	205	48
Gabapentin	Gabapentin	196	34
Tamsulosin Hcl	Tamsulosin Hcl	183	36
Furosemide	Furosemide	169	46
Sertraline Hcl	Sertraline Hcl	164	34
Trazodone Hcl	Trazodone Hcl	159	41
Lisinopril	Lisinopril	150	37
Potassium Chloride	Potassium Chloride	145	33
Metoprolol Tartrate	Metoprolol Tartrate	143	29
Metoprolol Succinate	Metoprolol Succinate	124	44
Metformin Hcl	Metformin Hcl	113	30
Pantoprazole Sodium	Pantoprazole Sodium	112	25
Losartan Potassium	Losartan Potassium	109	33
Ropinirole Hcl	Ropinirole Hcl	109	17
Buspirone Hcl	Buspirone Hcl	108	22
Escitalopram Oxalate	Escitalopram Oxalate	105	24
Divalproex Sodium	Divalproex Sodium	91	19
Clopidogrel	Clopidogrel Bisulfate	80	24
Levetiracetam	Levetiracetam	80	11
Hydrochlorothiazide	Hydrochlorothiazide	78	19
Memantine Hcl	Memantine Hcl	77	14
Ondansetron Odt	Ondansetron	76	11
Famotidine	Famotidine	74	14
Risperidone	Risperidone	74	16
Albuterol Sulfate Hfa	Albuterol Sulfate	72	27
Ozempic	Semaglutide	69	suppressed
Mirtazapine	Mirtazapine	68	18
Incruse Ellipta	Umeclidinium Bromide	67	suppressed
Duloxetine Hcl	Duloxetine Hcl	66	16
Hydralazine Hcl	Hydralazine Hcl	63	13
Montelukast Sodium	Montelukast Sodium	61	17
Meloxicam	Meloxicam	58	23
Gemtesa	Vibegron	56	suppressed
Carvedilol	Carvedilol	55	18
Donepezil Hcl	Donepezil Hcl	53	12
Zolpidem Tartrate	Zolpidem Tartrate	46	11
Mounjaro	Tirzepatide	43	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	43	20
Prednisone	Prednisone	38	17
Lactulose	Lactulose	37	suppressed
Amiodarone Hcl	Amiodarone Hcl	35	suppressed
Celecoxib	Celecoxib	35	suppressed
Citalopram Hbr	Citalopram Hydrobromide	35	11
Atenolol	Atenolol	34	suppressed
Jardiance	Empagliflozin	34	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	34	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	12
Metformin Hcl Er	Metformin Hcl	33	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	32	suppressed
Olanzapine	Olanzapine	32	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	30	suppressed
Sucralfate	Sucralfate	30	suppressed
Fluticasone Propionate	Fluticasone Propionate	29	12
Finasteride	Finasteride	28	suppressed
Humulin R	Insulin Regular, Human	28	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Tizanidine Hcl	Tizanidine Hcl	28	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	27	suppressed
Ibuprofen	Ibuprofen	27	suppressed
Myrbetriq	Mirabegron	27	suppressed
Linzess	Linaclotide	26	suppressed
Azithromycin	Azithromycin	25	19
Bumetanide	Bumetanide	25	suppressed
Allopurinol	Allopurinol	23	suppressed
Breo Ellipta	Fluticasone/Vilanterol	23	suppressed
Digoxin	Digoxin	23	suppressed
Pnv-Omega	Mv-Mins 71/Iron/Folic No.1/Dha	23	suppressed
Simvastatin	Simvastatin	23	suppressed
Xarelto	Rivaroxaban	23	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	22	suppressed
Lorazepam	Lorazepam	22	16
Pravastatin Sodium	Pravastatin Sodium	22	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	22	suppressed
Aripiprazole	Aripiprazole	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Lamotrigine	Lamotrigine	21	suppressed
Lubiprostone	Lubiprostone	20	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Vraylar	Cariprazine Hcl	20	suppressed
Warfarin Sodium	Warfarin Sodium	20	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	19	12
Midodrine Hcl	Midodrine Hcl	19	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Baclofen	Baclofen	18	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Galantamine Hbr	Galantamine Hbr	18	suppressed
Primidone	Primidone	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Chlorpromazine Hcl	Chlorpromazine Hcl	17	suppressed
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Risperdal Consta	Risperidone Microspheres	17	suppressed
Budesonide	Budesonide	16	suppressed
Cephalexin	Cephalexin	16	11
Clonazepam	Clonazepam	16	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	16	suppressed
Pregabalin	Pregabalin	16	suppressed
Sodium Chloride	0.9 % Sodium Chloride	16	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	15	suppressed
Amantadine	Amantadine Hcl	15	suppressed
Glipizide	Glipizide	15	suppressed
Prazosin Hcl	Prazosin Hcl	15	suppressed
Prednisolone Acetate	Prednisolone Acetate	15	suppressed
Spironolactone	Spironolactone	15	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Carbamazepine	Carbamazepine	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	suppressed
Fluconazole	Fluconazole	14	suppressed
Heparin Sodium	Heparin Sodium,porcine	14	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Zonisamide	Zonisamide	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Diltiazem Hcl	Diltiazem Hcl	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	13	suppressed
Latanoprost	Latanoprost	13	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	13	suppressed
Nuedexta	Dextromethorphan Hbr/Quinidine	13	suppressed
Oxcarbazepine	Oxcarbazepine	13	suppressed
Temazepam	Temazepam	13	suppressed
Topiramate	Topiramate	13	suppressed
Tramadol Hcl	Tramadol Hcl	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Morphine Sulfate	Morphine Sulfate	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Oxycodone Hcl	Oxycodone Hcl	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error